Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Ovarian Epithelial × relacorilant × 1 year × Clear all

Sponsor

Conditions

Ovarian Neoplasms 3 Hypertension 3 Fallopian Tube Neoplasms 3 Diabetes Mellitus, Type 2 3 Cushing Syndrome 3 ACTH Syndrome, Ectopic 3 Prostatic Neoplasms 2 Pituitary ACTH Hypersecretion 2 Peritoneal Neoplasms 2 Ovarian Diseases 1 Neoplasms by Site 1 Neoplasms 1 Genital Neoplasms, Female 1 Fallopian Tube Diseases 1 Endometrial Neoplasms 1 Carcinoma, Pancreatic Ductal 1 Adrenocortical Carcinoma 1 Adrenal Cortex Neoplasms 1 Adenocarcinoma 1

Interventions

Paclitaxel 12 Carboplatin 8 pembrolizumab 7 Bevacizumab 7 liposomal doxorubicin 5 Nivolumab 5 mirvetuximab soravtansine 4 Topotecan 4 ribociclib 3 olaparib 3 Fulvestrant 3 Drug Therapy 3 rucaparib 2 pegfilgrastim 2 palbociclib 2 oregovomab 2 niraparib 2 fludarabine phosphate 2 fludarabine 2 Irinotecan 2 Hyperthermic Intraperitoneal Chemotherapy 2 Gemcitabine 2 Cyclophosphamide 2 Blood Specimen Collection 2 1-dodecylpyridoxal 2 trastuzumab deruxtecan 1 spartalizumab 1 sargramostim 1 sacituzumab govitecan 1 isoquercitrin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡